Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome

International Journal of Gynecology and Obstetrics

Volumn 109, Issue 3, 2010, Pages 239-241

  El Mazny, Akmal ^a   Abou Salem, Nermeen ^a   El Sherbiny, Walid ^a   El Mazny, Ahmed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Dyslipidemia; Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FEMALE INFERTILITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL;

EID: 77951640176     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.01.014     Document Type: Article

References (25)

1. Speroff L., and Fritz M. Clinical Gynecologic Endocrinology and Infertility. 7th ed. (2005), Lippincott Williams & Wilkins, New York, NY, USA 485-513
2. Dokras A., Bochner M., Hollinrake E., Markham S., Vanvoorhis B., and Jagasia D.H. Screening women with polycystic ovarian syndrome for metabolic syndrome. Obstet Gynecol 106 1 (2005) 131-137
3. Apridonidze T., Essah P.A., Iuorno M.J., and Nestler J.E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 90 4 (2005) 1929-1935
4. Vural B., Caliskan E., Turkoz E., Kilic T., and Demirci A. Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome. Hum Reprod 20 9 (2005) 2409-2413
5. Azziz R. How prevalent is metabolic syndrome in women with polycystic ovary syndrome?. Nat Clin Pract Endocrinol Metab 2 3 (2006) 132-133
6. Essah P.A., and Nestler J.E. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 29 3 (2006) 270-280
7. The Rotterdam ESHRE-ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 1 (2004) 41-47
8. Balen A.H., Laven J.S., Tan S.L., and Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 6 (2003) 505-514
9. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Polycystic ovary syndrome. Int J Gynecol Obstet 80 3 (2003) 335-348
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 19 (2001) 2486-2497
11. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1: Diagnosis and classification of diabetes mellitus (1999), WHO, Geneva, Switzerland
12. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 8 (1998) 2694-2698
13. Nestler J.E., Stovall D., Akhter N., Iuorno M.J., and Jakubowiez D.J. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77 2 (2002) 209-215
14. Ovalle F., and Azziz R. Insulin resistance, polycystic ovary syndrome, type 2 diabetes mellitus. Fertil Steril 77 6 (2002) 1095-1105
15. Mor E., Zograbyan A., Saadat P., Bayrak A., Tourgeman D., Zhang C., et al. The resistant subphenotype of polycystic ovary syndrome: clinical parameters and pathogenesis. Am J Obstet Gynecol 190 6 (2004) 1654-1660
16. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity in polycystic ovary syndrome. Diabetes 38 9 (1989) 1165-1174
17. Ferrannni E., Natali A., Bell P., Cavallo-Perin P., Lalic N., and Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest 100 5 (1997) 1166-1173
18. Arner P. Control of lipolysis and its relevance to development of obesity in man. Diabetes Metab Rev 4 5 (1988) 507-515
19. Slowińska-Srzednicka J., Zgliczyński S., Wierzbicki M., Srzednicki M., Stopińska-Gluszak U., Zgliczyński W., et al. The role of hyperinsulinemia in the development of lipid disturbances in non obese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 14 7 (1991) 569-575
20. Robinson S., Henderson A.D., Gelding S.V., Kiddy D., Niththyananthan R., Bush A., et al. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) 44 3 (1996) 277-284
21. Legro R.S., Kunselman A.R., and Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med 111 8 (2001) 607-613
22. Mather K.J., Kwan F., and Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril 73 1 (2000) 150-156
23. Cho L.W., and Atkin S.L. Cardiovascular risk in women with polycystic ovary syndrome. Minerva Endocrinol 32 4 (2007) 263-273
24. Orio F., Vuolo L., Palomba S., Lombardi G., and Colao A. Metabolic and cardiovascular consequences of polycystic ovary syndrome. Minerva Ginecol 60 1 (2008) 39-51
25. Roa Barrios M., Arata-Bellabarba G., Valeri L., and Velázquez-Maldonado E. Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome. Endocrinol Nutr 56 2 (2009) 59-65